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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S382Purpose: While knee osteoarthritis (KOA) is typically a slowly pro-
gressive disorder, it has recently been appreciated that 5–17% of knees
progress rapidly (e.g. from normal to end-stage structural damage
within 4 years). Unfortunately, little is known about risk factors for this
phenotype of OA. Understanding the differences among individuals
with rapid KOA, non-rapid KOA, or no KOA may inform prognostic
testing, pre-emptive interventions, and increase our understanding of
the nature of KOA progression. Therefore, we compared baseline
descriptive characteristics among individuals who develop rapid KOA,
non-rapid KOA, or no KOA within the Osteoarthritis Initiative.
Methods: In the Osteoarthritis Initiative (OAI) we only studied partic-
ipants free of any knee OA on their baseline radiographs (Kellgren-
Lawrence [KL] < 2). We compared three groups: 1) rapid KOA: at least
one knee progressed to end-stage KOA (KL Grade 3 or 4) within 48
months, 2) non-rapid progression: at least one knee increased inTable. Baseline Descriptive Characteristics of Individuals with and without Rapid Knee Osteoarthritis (KOA) Progression.
No KOA (n ¼ 1325)
n (%) or mean (SD)
Non-rapid KOA (n ¼ 187)
n (%) or mean (SD)
Rapid KOA (n ¼ 54)
n (%) or mean (SD)
Univariate
Analyses1 p-value
Females 759 (57.3%) 122 (65.2%) 34 (63.0%) 0.0932
Race other than white (n miss ¼ 2) 177 (13.4%) 34 (18.2%) 8 (14.8%) 0.205
Age (years) 59.2 (9.2) 58.0 (8.3) 61.8 (8.6) 0.0232
BMI (kg/m2) 27.1 (4.4) 27.8 (4.5) 28.9 (4.7) 0.0022
Abnormal Weight Circumference (n miss ¼ 78) 847 (67.2%) 127 (73.0%) 40 (74.1%) 0.197
Systolic blood pressure (mm Hg) 121.1 (15.9) 118.4 (13.1) 123.1 (14.1) 0.0472
Fallen in past 12 mo (n miss ¼ 27) 433 (33.2%) 63 (34.4%) 21 (41.2%) 0.479
Static knee malalignment (Varus or valgus, n miss ¼ 79)3 992 (78.9%) 122 (69.7%) 40 (74.1%) 0.0202
Socio-economic Status
No health insurance THAT covers Rx (n miss ¼ 23) 117 (8.9%) 12 (6.6%) 8 (15.7%) 0.126
Income < $50K (n miss ¼ 52) 403 (31.4%) 48 (27.0%) 22 (43.1%) 0.0872
Less than a College Degree (n miss ¼ 8) 434 (32.9%) 73 (39.5%) 16 (30.8%) 0.186
Self-reported health assessments
Frequent knee pain on most days of a month
in past year (n miss ¼ 1)
502 (37.9%) 77 (41.2%) 25 (46.3%) 0.344
WOMAC pain Score 2.2 (2.8) 2.1 (2.6) 2.7 (3.0) 0.346
Charlson Comorbidity Score > 0 (n miss ¼ 2) 264 (20.1%) 28 (15.2%) 14 (28.0%) 0.0992
SF-12 physical summary score (n miss ¼ 13) 51.5 (7.8) 51.7 (7.6) 50.8 (9.7) 0.773
SF-12 Mental Summary Score (n miss ¼ 13) 53.4 (7.5) 53.8 (7.5) 53.4 (7.7) 0.733
Depression score (CES-D; n miss ¼ 11) 6.0 (6.3) 5.6 (6.1) 6.1 (5.9) 0.708
Physical activity score (PASE score ; n miss ¼ 7) 169 (82) 177 (82) 182 (91) 0.250
Other Joints
Right hand bony enlargements (n miss ¼ 20) 697 (53.4%) 107 (57.5%) 31 (57.4%) 0.498
Left hand bone enlargements (n miss ¼ 21) 617 (47.3%) 93 (50.0%) 32 (59.3%) 0.191
Any back pain, past 30 days (n miss ¼ 2) 781 (59.0%) 99 (52.9%) 36 (66.7%) 0.134
Doctor diagnosed back OA (n miss ¼ 55) 190 (14.9%) 30 (16.5%) 11 (22.0%) 0.346
Doctor diagnosed hip OA (n miss ¼ 44) 94 (7.3%) 11 (6.0%) 5 (9.8%) 0.624
Doctor diagnosed hand OA (n miss ¼ 44) 215 (16.7%) 21 (11.5%) 9 (17.7%) 0.200
Pharmacological interventions
Either knee, used meds for pain, past 12 mo (n miss ¼ 2) 571 (43.2%) 86 (46.0%) 27(50%) 0.490
Either knee, injection for arthritis, past 6 m (n miss ¼ 1) 13 (1.0%) 4 (2.1%) 2 (3.7%) 0.094
Take any pain medication today (for any pain) 124 (9.4%) 18 (9.6%) 8 (14.8%) 0.410
OTC NSAIDs for joint pain, past 30 days (n miss ¼ 3) 213 (16.1%) 27 (14.6%) 15 (27.8%) 0.0592
Acetaminophen for joint pain, past 30 day (n miss ¼ 2) 112 (8.5%) 12 (6.5%) 7 (13.0%) 0.303
Rx NSAIDs for joint pain, past 30 days (n miss ¼ 1) 56 (4.2%) 9 (4.8%) 1 (1.9%) 0.634
COXIBS for joint pain, past 30 days 86 (6.5%) 9 (4.8%) 4 (7.4%) 0.641
Strong Rx Pain Med for joint pain, past 30 days 29 (2.2%) 3 (1.6%) 0 (0.0%) 0.485
Note. 1) Chi-squares and analyses of variance (with Tukey HSD post-hoc comparisons as needed). 2) Variables that were explored in more advanced analyses. 3) Static
malalignment based on a clinical examination with a goniometer. CES-D ¼ Center for Epidemiologic Study Depression Scale Score; PASE ¼ Physical Activity Scale for the
Elderly; OTC ¼ over the counter; NSAIDs ¼ nonsteroidal anti-inﬂammatory drugs; Rx ¼ Prescription; COXIBS ¼ COX-2 selective nonsteroidal anti-inﬂammatory drugs.radiographic scoring within 48 months (excluding those deﬁned as
rapid KOA), and 3) No KOA: no change in KL grade by 48-month follow-
up. Self-reported and objective measures (see table) were acquired
based on a standard protocol. We ﬁrst evaluated the distribution of
baseline descriptive characteristics among the three groups with Chi-
square tests or analyses of variance (with Tukey HSD post-hoc com-
parisons as needed). Based on the initial analyses we entered baseline
descriptive characteristics that may distinguish individuals with rapid
KOA (i.e. variables with p values< 0.10 and a sufﬁcient sample size) into
a multinomial stepwise logistic regression model to determine if they
were associated with rapid KOA as an outcome compared with no KOA
or non-rapid KOA.
Results: Individuals with rapid KOA tended to be older and have greater
baseline body mass index (BMI) and systolic blood pressure (see Table).
After adjusting for evaluated sex, systolic blood pressure, income,presence of comorbidity, static knee malalignment, and use of over-the-
counter nonsteroidal anti-inﬂammatory drugs, only baseline age (odds
ratio [OR]¼ 1.04, 95% conﬁdence interval [CI]¼ 1.01–1.08; per year) and
BMI (OR ¼ 1.10, 95% CI ¼ 1.03–1.17; per kg/m2) were greater among
individuals with rapid KOA compared with those with no KOA. In
comparison with individuals with non-rapid KOA, only age was asso-
ciated with developing rapid KOA (OR ¼ 1.05, 95% CI ¼ 1.01–1.09; per
year).
Conclusions: Among individuals with no radiographic KOA, those who
develop rapid KOA tended to be older than those with no KOA or non-
rapid KOA. Furthermore, individuals with rapid KOA tended to have a
higher BMI than those with no KOA. While we often discuss rapid onset
of KOA among young individuals with a history of knee injury we must
not lose sight that older individuals may also be at risk for rapid KOA.679
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Purpose: Obesity is strongly linked to knee OA and is considered a
risk factor for both incidence and progression. Obese patients with
knee OA tend to walk slower, have shorter step length, cadence
and single limb support (SLS). Most obese patients fail to comply
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function.
Several biomechanical treatments for knee OA have emerged with the
goal of reducing pain, improving function and halting disease pro-
gression. These treatments aim to unload the diseased articular surface
by using wedged insoles, foot orthoses, unique shoes or valgus braces.
The aim of this study was to examine the effect of a biomechanical,
home-based, gait training device on gait patterns of obese patients
suffering from knee OA.
Methods: This was a retrospective analysis of 105 (32 males and 73
females) obese patients (BMI >30 kg/m2) with knee OA. All patients
underwent a computerized gait test to characterize spatio-temporal
parameters and were asked to complete The Western Ontario and
McMaster Osteoarthritis Index (WOMAC) questionnaire and SF-36
Health Survey. Patients were ﬁtted with the biomechanical gait training
device and received home-based exercise program. Patients returned to
the clinic for additional assessments of gait patterns and clinical
symptoms following 3 and 12 months of therapy. One-way repeated
measure ANOVA was applied to determine signiﬁcant changes over
time, p-value was set to p < 0.05.
Results: A signiﬁcant reduction in pain, stiffness and functional
limitation was seen after 3 months of therapy with an additional
improvement following 12 months of therapy. Pain decreased by
34.7% following 3 months of therapy and further decreased by an
additional 11.0%. Functional limitation decreased by 35.0% following
3 months of therapy and further decreased by an additional 9.7%.
Both Physical Scale and Mental Scale of the SF-36 increased sig-
niﬁcantly following 3 months of therapy and further increased fol-
lowing 12 months of therapy.
Signiﬁcant improvements in gait pattern were found in all parameters
after 3 months of therapy with an additional improvement following 12
months of therapy. Gait velocity increased by 11.8% following 3 months
of therapy and further improved by an additional 4.3%. SLS of the more
symptomatic knee increase by 2.5% following 3 months of therapy and
further improved by an additional 1.1%.
Conclusions: Obese patients with knee OA complied with a home-
based exercise program using a biomechanical gait training device.
Patients demonstrated a signiﬁcant improvement in gait patterns and
clinical symptoms mainly after 3 months of therapy with an addi-
tional improvement after 12 months of therapy. This therapy may
help obese patient with knee OA to become active and persist with
an exercise program that will lead them to relieved pain and
improved function.680
INCIDENCE OF TOTAL KNEE AND HIP REPLACEMENT DUE TO
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Purpose: The increase in prevalence of osteoarthritis (OA) in post-
menopausal women suggests that changes in either circulating sex
steroid concentrations or tissue response to sex steroids may have a role
in the pathogenesis of OA. The aim of this study was to examine
whether circulating sex steroid concentrations were associated with
the incidence of total knee and hip replacement for OA.
Methods: 2,621 women with circulating sex steroid concentrations
measured in blood samples drawn at recruitment (1990-1994) were
selected from the Melbourne Collaborative Cohort Study (MCCS). The
incidence of total knee and hip replacement for OA during 2001-2011
was determined by linking MCCS records to the Australian Orthopaedic
Association National Joint Replacement Registry.
Results: 115 women had total knee replacement and 99 had total hip
replacement due to OA. Greater log estradiol concentration was asso-
ciated with a lower incidence of knee replacement (hazard ratio (HR)
0.70, 95% CI 0.50-0.96) and greater log androstenedione concentration
was associated with a lower incidence of hip replacement (HR 0.70, 95%
CI 0.52-0.93). In contrast, greater log sex hormone binding globulin
(SHBG) concentration was associated with greater incidence of hip
replacement (HR 1.70, 95% CI 1.05-2.77).
Conclusions: Lower estradiol concentration is a risk factor for knee OA;
lower androstenedione concentration and higher SHBG concentration
are risk factors for hip OA in women. The ﬁndings suggest a role for
circulating sex steroids in the pathogenesis of OA and that modifying
these steroid concentrations may provide potential strategies for the
prevention and treatment of large joint OA.
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Purpose: Osteoarthritis (OA) and osteoporosis (OP) are diseases
affecting joints and bones. OA is generally assessed using radiographs
and OP by Dual Energy X-ray Absorptiometry (DXA) scans however OA
can also be assessed on DXA images using Kellgren Lawrence Grading
(KLG). OP is a well understood disease, with effective treatments (e.g.
bisphosphonates) that prevent or delay fracture. However we do not
fully understand OA and there are no effective disease modifying drugs.
